{"name":"407 Doctors","slug":"407-doctors","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWGNhU3pjS0lJMVBlckZlSWh4djlqS2c5b285R3JsVVJ6T1ktSFBfaXRYWUU3UDBzWEt1VHNJZWlCWE04TnBFMUpyNVNIemxvNXFwQzZRazU2TWhFWHl5bmVIWi1HMVp6ZWtMLWJmVGNuZk14Q3RWUDBPenhuakpqUTNBZmxxRklYOHk0?oc=5","date":"2026-02-05","type":"regulatory","source":"The Lancet","summary":"Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials - The Lancet","headline":"Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPR0NLY1VRT2l6UmdZdHRWMUlvRGo3X0dPSzdpZUk4UE5hWlhoRXVzeXY2OC1CalprbklHRy1RNjVVU2UzY3o3eDVfWC1DbGt5eklvNDRPRmpkSEJMZW1ZQ1V0MHhxVmdtWS1tbExSZVFLWDdpNG1EcEdrNnRxd0NqU0tfSGR4WVdaVVlYVVE2eGdRcmxmSVFDOWdTOGNpZw?oc=5","date":"2025-07-29","type":"trial","source":"PharmaTimes","summary":"Exonate to launch phase 2b trial of EXN407 for diabetic eye disease - PharmaTimes","headline":"Exonate to launch phase 2b trial of EXN407 for diabetic eye disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPeXpLVnNpcEdZX3NaNG1Dd2JiNTBXeDgzSXlkZmJuckxwbHk4U2RmZHpwa2VTT0NYemZucGRqNHlMS2J6bzc5Z1VCcFJuRzg1MVFMekxObWpGYlR1WU96YWx5V1hDTmpkRnVHc2piQnp2cWh4enhmczZxMWlySFozZnRMa0dBOHIxTlc5S3E0SWJXUUxjd3FGTmN6NHFDakxydzVjejhaR0hNUkotcVBldFJmY08yZmFJV09zYlk5bzZEdFk5UjQwb2ZCZUtycnBhLThvSVoxbkxDbVhTS3M5NDV5NGl5NXQ5d2d0cnU2eUhHaGhNWFZoX1R0MFE?oc=5","date":"2025-06-04","type":"pipeline","source":"uni-lj.si","summary":"The promotion of 407 Doctors of Sciences and awarding of nine recognitions of major works of art at the University of Ljubljana - uni-lj.si","headline":"The promotion of 407 Doctors of Sciences and awarding of nine recognitions of major works of art at the University of Lj","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE0zMFhWYWhtRU9mZkNTSEFyMGYyeVpIUEF3YWtWREh5QUlTbXlERk8wRmFLSzlqTzdVVFdCbW80ckYtemNRdmxIODlzR1JCNFRfX01NbDhiY2tSN3pSR3RkOXVEWGVxZw?oc=5","date":"2012-11-21","type":"pipeline","source":"Orlando Magazine","summary":"Orlando's Top Doctors - Orlando Magazine","headline":"Orlando's Top Doctors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}